PACIFIC-R: Real-world characteristics of unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy

Authors :: McDonald, F.
Mornex, F.
Garassino, M. C.
Filippi, A. R.
Christoph, D.
Haakensen, V. D.
Agbarya, A.
Van den Heuvel, M.
Vercauter, P.
Chouaid, C.
Pichon, E.
Siva, S.
Steinbusch, L.
Peretz, I.
Solomon, B.
Decoster, L.
Sawyer, W.
Allen, A.
Licour, M.
Girard, N.
Faculty of Physical Education and Physical Therapy
Clinical sciences
Medical Oncology
Laboratory of Molecular and Medical Oncology
Publication Year :: 2021
Publisher :: International Association for the Study of Lung Cancer, 2021.
Abstract: NOT AVAILABLE

Tools